Skip to main content

Find Clinical Trials

Home
Conditions
Glomerulonephritis

Clinical trial condition

Glomerulonephritis

Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.

506 public trials 166 recruiting studies

Refine in advanced search Browse all conditions

Glomerulonephritis trial results

Completed

Total Lymphoid Irradiation (TLI) to Prevent Focal Segmental Glomerulosclerosis (FSGS)Recurrence in the Renal Graft

NCT00353535

Conditions: Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Hospital das Clinicas - Division of Urology and Radiotherapy - University of Sao Paulo São Paulo, Brazil

View Trial Details

Completed

Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone

NCT00268567

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations: Renal Division, Peking University First Hospital Beijing, China

Department of Nephrology, Kidney Center and key Lab of PLA, Chinese General Hospital of PLA Beijing, China

Division of Nephrology, Nanfang Hospital, Southern Medical University Guangzhou, China

Renal Division, the First Affiliated Hospital, Sun Yat-sen University Guangzhou, China

View Trial Details

Completed

Mycophenolate Mofetil in Membranous Nephropathy

NCT00135967

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
Locations: Department of Nephrology Radboud University Nijmegen Medical Centre Nijmegen, Netherlands

View Trial Details

Completed

Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy

NCT00006137

Conditions: Autoimmune Diseases, Disease Attributes, Female Urogenital Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis

NCT00004305

Conditions: Autoimmune Diseases, Disease Attributes, Female Urogenital Diseases, +13 more
Locations: Ohio State University Columbus, Ohio, United States

View Trial Details

Withdrawn

A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)

NCT06984341

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations: University of Alabama at Birmingham: The Kirklin Clinic Birmingham, Alabama, United States

University of Iowa Iowa City, Iowa, United States

View Trial Details